Mepilex Border Ag

Apósito antimicrobiano autoadhesivo de espuma y silicona suave

Product: REF {{ store.currentProductVariant?.productId }}

{{ feature }}

Certified by ISCC Read more about the ISCC certification
FSC certified paper Read more about the FSC certification

Show more Show less
{{ document.name }}

{{ document.fileType }}

{{ document.date }}

Download now
Mepilex Border Ag esta compuesto de una capa de contacto con la herida de silicona suave Safetac®, una capa de espuma de poliuretano absorbente que contiene sulfato de plata y está coloreada con carbón activado, una capa de fibras superabsorbentes, tejido sin tejer y una película transpirable e impermeable. Safetac® es una tecnología adhesiva patentada y desarrollada por Mölnlycke que minimiza el dolor de los pacientes y el traumatismo en las heridas y la piel sana. Mepilex Border Ag es un apósito de espuma y silicona suave que absorbe el exudado, mantiene húmedo el entorno de cicatrización y tiene propiedades antimicrobianas. Mepilex Border Ag contiene sulfato de plata para crear una barrera bacteriana eficaz e inactivar una amplia gama de patógenos relacionados con las heridas (bacterias y hongos), como se ha demostrado <i>in vitro</i>. Al reducir el número de microorganismos, Mepilex Border Ag también reduce el olor. Mepilex Border Ag ha demostrado inactivar patógenos relacionados con las heridas hasta 7 días <i>in vitro</i>.

01
Fast (as from 30 min, in vitro), sustained (up to 7 days, in vitro) and broad range antimicrobial action (in vitro)

02
Efficient exudate handling by minimising leakage and a high absorption, retention and MVTR. This could help support a reduced number of dressing changes
Mölnlycke Health Care. NAMSA reference 10C_39972_01. (Modified) ISO 20743:2007 Determination of antibacterial activity of antibacterial finished products. Data on file, 2010. Mölnlycke Health Care. NAMSA references 09C_29253_01, 09C_29252_01, 09C_29253_02. ASTM E2149-01 Determining the antimicrobial activity of immobilized antimicrobial agents under dynamic contact conditions. Data on file, 2009. Mölnlycke Health Care. T- 1050 Shake flask method for determination of antimicrobial effect of material and products. Data on file, 2009. Mölnlycke Health Care. T- 1050 Shake flask method for determination of antimicrobial effect of material and products. Data on file, 2009.

Huss, F., Thorfinn, J. An open, non-controlled, postmarketing investigation evaluating the experience of using a self-adherent antimicrobial soft silicone, silver containing, foam dressing, Mepilex Border Ag, in second degree burns. PMCF study MxB Ag 02 from Mölnlycke Health Care. Unpublished data, 2011. Latenser, B., Alvarez, OM., Treadwell, T. Open multicentre investigation to evaluate signs and symptoms of local inflammation/infection on chronic ulcers and partial thickness burns when using Mepilex Border Ag as an anti-microbial wound dressing. PMCF study MxB Ag 01 from Mölnlycke Health Care. Unpublished data, 2012. Kles C.L., Murrah, C.P., Smith, K., Baugus- Wellmeier, E., Hurry, T., Morris, C.D. Achieving and sustaining zero. Preventing surgical site infections after isolated coronary artery bypass with saphenous vein harvest through implementation of a staffdriven quality improvement process. Dimensions of Critical Care Nursing 2015;34(5):265-272.